Folate receptor targeted biodegradable polymeric doxorubicin micelles

Journal of Controlled Release

Volumn 96, Issue 2, 2004, Pages 273-283

  Yoo, Hyuk Sang ^a   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Doxorubicin; Folate; Micelle; PLGA; Targeting

Indexed keywords

BIODEGRADATION; BLOCK COPOLYMERS; CELLS; IMAGE ANALYSIS; MICELLES; POLYETHYLENE GLYCOLS; TUMORS;

CYTOMETRY; CYTOTOXICITY;

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; COPOLYMER; DOXORUBICIN; FOLIC ACID; MACROGOL; POLYGLACTIN; RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BIODEGRADABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DEGRADATION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; MICELLE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TUMOR REGRESSION; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARRIER PROTEINS; DOXORUBICIN; FEMALE; FLOW CYTOMETRY; LACTIC ACID; MICE; MICE, NUDE; MICELLES; MICROSCOPY, CONFOCAL; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYGLYCOLIC ACID; POLYMERS; RECEPTORS, CELL SURFACE; TIME FACTORS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 1842638560     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.02.003     Document Type: Article

References (26)

1. Cummings J., McArdle C.S. Studies on the in vivo disposition of adriamycin in human tumors which exhibit different responses to the drug. Br. J. Cancer. 53:1986;835-838.
2. Goren D., Horowitz A.T., Tzemach D., Tarshish M., Zalipsky S., Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux. Clin. Cancer Res. 6:2000;1949-1957.
3. Weitman S.D., Weinberg A.G., Coney L.R., Zurawski V.R., Jennings D.S., Kamen B.A. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 52:1992;6708-6711.
4. Lu J.Y., Lowe D.A., Kennedy M.D., Low P.S. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. J. Drug Target. 7:1999;44-53.
5. Lu Y., Low P.S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol. Immunother. 51:2002;153-162.
6. Reddy J.A., Low P.S. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J. Control. Release. 64:2000;27-37.
7. Wang S., Lee R.J., Cauchon G., Gorenstein D.G. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethyleneglycol. Proc. Natl. Acad. Sci. 92:1995;3318-3322.
8. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Mandelbaum-Shavit F., Qazen M.M., Zalipsky S. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconj. Chem. 10:1999;289-298.
9. Guo W., Lee T., Sudimack J.J., Lee R.J. Receptor-specific delivery of liposomes via folate-PEG-chol. J. Liposome Res. 10:2000;179-195.
10. Lee R.J., Low P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta. 1233:1995;134-144.
11. Pan X.Q., Wang H., Lee R.J. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm. Res. 20:2003;417-422.
12. Lee R.J., Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:1994;3198-3204.
13. Lee E.S., Na K., Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J. Control. Release. 91:2003;103-113.
14. Kataoka K., Kwon G., Yokoyama M., Okano T., Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J. Control. Release. 24:1992;119-132.
15. Kwon G.S., Okano T. Polymeric micelle as new drug carriers. Adv. Drug Deliv. Rev. 16:1996;107-116.
16. Yokoyama M., Kwon G.S., Naito M., Okano T., Sakurai Y., Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconj. Chem. 3:1992;295-301.
17. Yoo H.S., Park T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Control. Release. 70:2001;63-70.
18. Yoo H.S., Lee E.A., Park T.G. Doxorubicin conjugated biodegradable polymeric micelles having acid-cleavable linkages. J. Control. Release. 82:2002;17-27.
19. Liggins R.T., Burt H.M. Polyether-polyester di-block copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv. Drug Deliv. Rev. 54:2002;191-202.
20. Shiah J.G., Dvorak M., Kopecekova P., Sun Y., Peterson C.M., Kopecek J. Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl) methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur. J. Cancer. 37:2001;131-139.
21. Kataoka K., Matsumoto T., Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., Kwon G.S. Doxorubicin-loaded poly(ethylene glycol)-poly(ß- benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release. 64:2000;143-153.
22. Yang E., Tang W., Zhang K., Cheng L., Mack P.O.P. Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Lett. 117:1997;93-98.
23. Soma C.E., Dubernet C., Bentolila D., Benita S., Couvreur P. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials. 21:2000;1-7.
24. Shiah J.G., Sun Y., Peterson C.M., Kopecek J. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e6 and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. J. Control. Release. 61:1999;145-157.
25. Lawrence J.M., Petitti D.B., Watkins M., Umekubo M.A. Trends in serum folate after food fortification. Lancet. 354:1999;915-916.
26. 125I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous ad ministration to nude mice bearing hepatic human colon carcinoma. J. Drug Target. 3:1996;385-390.